A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 3,470 shares of NVO stock, worth $356,126. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,470
Previous 3,320 4.52%
Holding current value
$356,126
Previous $473,000 12.68%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $17,860 - $21,812
150 Added 4.52%
3,470 $413,000
Q2 2024

Jul 30, 2024

SELL
$122.71 - $146.91 $167,744 - $200,825
-1,367 Reduced 29.17%
3,320 $473,000
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $2,042 - $2,718
20 Added 0.43%
4,687 $601,000
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $409,669 - $492,135
4,667 New
4,667 $482,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.